Table 3.
Treatment-emergent, treatment-related adverse events summarized by maximum severity grade for ≥5% (all grades; decreasing frequency) of subjects in either treatment group in study A4061032

Treatment-emergent, treatment-related adverse events summarized by maximum severity grade for ≥5% (all grades; decreasing frequency) of subjects in either treatment group in study A4061032
